(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-11 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 198870
Date | Daily Closing Price | Open | High | Low | Volume |
11 Fri Oct 2024 | 8.31 | 8.09 | 8.45 | 8.07 | 0.743 times |
10 Thu Oct 2024 | 8.06 | 8.01 | 8.08 | 7.90 | 0.915 times |
09 Wed Oct 2024 | 8.06 | 7.91 | 8.10 | 7.88 | 0.931 times |
08 Tue Oct 2024 | 7.93 | 8.05 | 8.17 | 7.91 | 1.204 times |
07 Mon Oct 2024 | 8.05 | 8.12 | 8.15 | 8.00 | 0.945 times |
04 Fri Oct 2024 | 8.10 | 8.14 | 8.21 | 8.07 | 1.202 times |
03 Thu Oct 2024 | 8.10 | 8.18 | 8.36 | 8.08 | 1.008 times |
02 Wed Oct 2024 | 8.21 | 8.20 | 8.28 | 8.16 | 0.63 times |
01 Tue Oct 2024 | 8.21 | 8.06 | 8.28 | 8.04 | 1.136 times |
30 Mon Sep 2024 | 8.06 | 8.07 | 8.15 | 8.02 | 1.208 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 8.3, for a target of 8.2 or 8.1
Share price targets for Theravance Biopharma (TBPH)
Target Type | Value |
Downside Target | 7.44 |
Downside Target | 7.88 |
Downside Target | 8.28 |
Upside Target | 8.36 |
Upside Target | 8.42 |
Upside Target | 8.45 |
Upside Target | 9.01 |
Upside Target | 10.22 |
Upside Target | 10.42 |
Intraday share price targets for Theravance Biopharma (TBPH)
Target Type | Value |
Downside Intraday Target | 7.98 |
Downside Intraday Target | 7.64 |
Upside Intraday Target | 8.55 |
Upside Intraday Target | 8.78 |
Downside Intraday Target | 8.21 |
Weekly technical analysis of Theravance Biopharma (TBPH)
Date | Weekly Closing Price | Open | High | Low | Volume |
11 Fri Oct 2024 | 8.31 | 8.12 | 8.45 | 7.88 | 0.914 times |
04 Fri Oct 2024 | 8.10 | 8.07 | 8.36 | 8.02 | 1.079 times |
27 Fri Sep 2024 | 8.10 | 8.07 | 8.15 | 7.88 | 0.758 times |
20 Fri Sep 2024 | 8.01 | 8.19 | 8.42 | 7.99 | 1.216 times |
13 Fri Sep 2024 | 8.14 | 8.03 | 8.20 | 7.90 | 1.284 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
Date | Monthly Closing Price | Open | High | Low | Volume |
11 Fri Oct 2024 | 8.31 | 8.06 | 8.45 | 7.88 | 0.403 times |
30 Mon Sep 2024 | 8.06 | 8.18 | 8.42 | 7.88 | 0.378 times |
30 Fri Aug 2024 | 8.25 | 10.16 | 10.22 | 7.44 | 1.459 times |
31 Wed Jul 2024 | 10.11 | 8.46 | 10.42 | 8.19 | 1.048 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Theravance Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.1 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Theravance Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.1 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.